Compass Therapeutics Inc. Common Stock (CMPX)
Stock · NASDAQ · Health Care
$2.4as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$2.04
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
About CMPX
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops antibody-based therapeutics for the treatment of various human diseases in the United States. The company's lead product candidate, tovecimig, is a bispecific antibody that targets delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF-A), which are critical to angiogenesis and tumor vascularization. I…
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 39
- Website
- www.compasstherapeutics.com
Fundamentals
- 1-day range
- $2.03$2.18
- Market cap
- $358.37M
- P/E (trailing)
- —
- P/E (forward)
- -4.52
- EPS (trailing)
- $-0.39
- Dividend yield
- —
- Beta
- 0.82
- Avg. volume
- 3.66M
52-week range
$1.61$6.88
Next earnings: November 5, 2026 · EPS estimate $-0.12confirmed
Forecasts
12 analyst ratings
Buy 93%
Hold 7%
Sell 0%
1-year price forecast
High
$24
+900.0%
Median
$7
+191.7%
Low
$5
+108.3%
Compass Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- CMPXCompass Therapeutics Inc. Common Stock$2.4▼ 4.76%Market cap $358.37MP/E —$1.61$6.88
- LXEOLexeo Therapeutics Inc. Common Stock$4.87▼ 2.51%Market cap $357.27MP/E —$3.99$10.99
- PALIPalisade Bio Inc. Common Stock$2.01▼ 4.74%Market cap $362.78MP/E —$0.53$2.86
- IPSCCentury Therapeutics Inc. Common Stock$2.03▼ 9.19%Market cap $342.67MP/E —$0.435$3.04
- FENCFennec Pharmaceuticals Inc. Common Stock$12.19▲ 3.57%Market cap $378.17MP/E —$5.65$13.25
- AGENAgenus Inc. Common Stock$7.67▼ 1.79%Market cap $335.19MP/E 4.88$2.71$8.85
- XFORX4 Pharmaceuticals Inc. Common Stock$4.05▼ 4.26%Market cap $393.31MP/E 3.24$2.8$4.83
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CMPX Compass Therapeutics Inc. Common Stock | $358.37M | — | $2.4 | ▼ 4.76% | $1.61$6.88 |
| LXEO Lexeo Therapeutics Inc. Common Stock | $357.27M | — | $4.87 | ▼ 2.51% | $3.99$10.99 |
| PALI Palisade Bio Inc. Common Stock | $362.78M | — | $2.01 | ▼ 4.74% | $0.53$2.86 |
| IPSC Century Therapeutics Inc. Common Stock | $342.67M | — | $2.03 | ▼ 9.19% | $0.435$3.04 |
| FENC Fennec Pharmaceuticals Inc. Common Stock | $378.17M | — | $12.19 | ▲ 3.57% | $5.65$13.25 |
| AGEN Agenus Inc. Common Stock | $335.19M | 4.88 | $7.67 | ▼ 1.79% | $2.71$8.85 |
| XFOR X4 Pharmaceuticals Inc. Common Stock | $393.31M | 3.24 | $4.05 | ▼ 4.26% | $2.8$4.83 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Piper Sandler Maintains Overweight on Compass Therapeutics, Raises Price Target to $6Benzinga · 8/7/2026
- Compass Therapeutics Q2 EPS $(0.13) Misses $(0.11) EstimateBenzinga · 8/6/2026
Insider Activity
Insider Actions →Acquired
40.0K
Disposed
0
- Jonathan Anderman · April 29, 2026 · Grant25.0K @ $1.89
- Neil Lerner · April 29, 2026 · Grant15.0K @ $1.89
Institutional Ownership
March 31, 2026
- Total shares held
- 173.56M
- Total value held
- $919.58M
- Institutional holders
- 196
Top holders this quarter
- Unknown16.79M
- Unknown15.22M
- Unknown14.31M
- Unknown9.55M
- Unknown9.51M
- Unknown8.49M
- Unknown7.79M
- Unknown7.76M
- Unknown6.69M
- Unknown6.04M
See the full, filterable feed with live charts on the MarketWall dashboard.